Yifan Han
- Pharmacology top 0.2%
- Cholinesterase and Neurodegenerative Diseases 75
- Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms 18
-
- Neuroscience and Neuropharmacology Research 46
- Computational Theory and Mathematics top 0.5%
- Computational Drug Discovery Methods 27
-
- Alzheimer's disease research and treatments 42
-
- Nicotinic Acetylcholine Receptors Study 26
-
- Chemical synthesis and alkaloids 15
-
- Liver Disease Diagnosis and Treatment 11
Yifan Han
292 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Pharmacology 2.3k
- Complementary and alternative medicine 894
- Neurology 699
- Cellular and Molecular Neuroscience 1.2k
- Computational Theory and Mathematics 906
Countries citing papers authored by Yifan Han
This map shows the geographic impact of Yifan Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifan Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifan Han more than expected).
Fields of papers citing papers by Yifan Han
This network shows the impact of papers produced by Yifan Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifan Han. The network helps show where Yifan Han may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yifan Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 5 | |
| 11 | 2021 | 16 | |
| 12 | 2021 | 17 | |
| 13 | 2020 | 9 | |
| 14 | 2020 | 9 | |
| 15 | 2017 | 2 | |
| 16 | 2006 | 57 | |
| 17 | An AFLP linkage map using a hybrid population of Populus tomentosa | 2003 | 1 |
| 18 | An Approach to Sustainable Management of Population Genetic Resources of Trees II. Management Analysis of Plantation and Natural Population of Some Autochthonous Tree Species in China | 2001 | 1 |
| 19 | An approach to sustainable management of population genetic resources of trees I. Relevant theoretical analyses of the information on population genetic variation | 2000 | 1 |
| 20 | 1999 | 24 |
About Yifan Han
Yifan Han is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Neurology, having authored 307 papers that have together received 9.0k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (75 papers), Neuroscience and Neuropharmacology Research (46 papers), Alzheimer's disease research and treatments (42 papers), Computational Drug Discovery Methods (27 papers), Nicotinic Acetylcholine Receptors Study (26 papers), Neuroinflammation and Neurodegeneration Mechanisms (18 papers), Chemical synthesis and alkaloids (15 papers) and Liver Disease Diagnosis and Treatment (11 papers). The work is most often cited by research in Pharmacology (2.3k citations), Complementary and alternative medicine (894 citations) and Neurology (699 citations). Yifan Han has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yuan‐Ping Pang, Paul R. Carlier, Shinghung Mak, Shengquan Hu, Zhengzhe Lai, Yinxiang Zeng, Xihong Lu, Shilei Xie, Haozhe Zhang and Wei Cui. Their work appears in journals such as Neuropharmacology, European Journal of Pharmacology, CNS Neuroscience & Therapeutics, Journal of Neurochemistry and Neuroreport.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.